MeSH term
Count | Immunotherapy, Active | 13 |
*Immunotherapy, Active | 25 |
Immunotherapy, Active/*methods | 11 |
*Immunotherapy, Active/methods | 1 |
Immunotherapy, Active/methods | 2 |
*Immunotherapy, Active/adverse effects | 1 |
Immunotherapy, Active/adverse effects/methods | 1 |
*Immunotherapy | 160 |
Immunotherapy | 323 |
Immunotherapy/standards | 1 |
Immunotherapy/*economics | 1 |
Immunotherapy/*methods | 129 |
*Immunotherapy, Adoptive | 62 |
Immunotherapy/methods | 82 |
*Immunotherapy/economics | 1 |
Immunotherapy/history | 1 |
Immunotherapy, Adoptive | 71 |
Immunotherapy/trends | 2 |
*Immunotherapy/methods | 7 |
Immunotherapy/methods/*trends | 1 |
Immunotherapy, Adoptive/methods | 12 |
Immunotherapy, Adoptive/*methods | 39 |
*Immunotherapy, Adoptive/methods | 1 |
*Immunotherapy/methods/trends | 2 |
*Immunotherapy/adverse effects | 2 |
Immunotherapy, Adoptive/*standards | 1 |
*Immunotherapy/*adverse effects | 1 |
Immunotherapy/*methods/trends | 2 |
Immunotherapy/adverse effects | 3 |
*Immunotherapy, Adoptive/adverse effects | 4 |
Immunotherapy, Adoptive/*methods/trends | 1 |
Immunotherapy/adverse effects/*methods | 3 |
Immunotherapy, Adoptive/adverse effects | 1 |
*Immunotherapy, Adoptive/economics/methods | 1 |
Immunotherapy, Adoptive/*adverse effects | 1 |
Immunotherapy, Adoptive/adverse effects/*methods | 2 |
Immunotherapy, Adoptive/adverse effects/methods | 1 |
*Immunity, Active | 3 |
Immunity, Active | 8 |
Biological Transport, Active | 180 |
*Biological Transport, Active | 2 |
*Euthanasia, Active, Voluntary | 4 |
*Surface-Active Agents | 1 |
Immunity, Active/*immunology | 1 |
Immunity, Active/*physiology | 1 |
Immunity, Active/genetics | 1 |
Surface-Active Agents | 10 |
Immunity, Active/immunology | 1 |
Surface-Active Agents/pharmacology | 9 |
Surface-Active Agents/*chemistry | 4 |
Biological Transport, Active/immunology | 5 |
Surface-Active Agents/metabolism | 3 |
Biological Transport, Active/physiology | 15 |
Surface-Active Agents/*pharmacology | 8 |
Antiretroviral Therapy, Highly Active | 302 |
*Antiretroviral Therapy, Highly Active | 306 |
Surface-Active Agents/*metabolism | 1 |
Active Transport, Cell Nucleus | 236 |
Biological Transport, Active/*physiology | 3 |
*Active Transport, Cell Nucleus | 40 |
Biological Transport, Active/genetics | 6 |
Biological Transport, Active/*genetics | 1 |
Euthanasia, Active/*legislation & jurisprudence | 1 |
Surface-Active Agents/chemistry | 3 |
Active Transport, Cell Nucleus/immunology | 5 |
Antiretroviral Therapy, Highly Active/*mortality | 1 |
Surface-Active Agents/chemistry/*toxicity | 1 |
Surface-Active Agents/*adverse effects | 1 |
Antiretroviral Therapy, Highly Active/mortality | 1 |
Antiretroviral Therapy, Highly Active/trends | 1 |
Antiretroviral Therapy, Highly Active/utilization | 2 |
Biological Transport, Active/*drug effects | 2 |
Antiretroviral Therapy, Highly Active/*economics | 4 |
Active Transport, Cell Nucleus/genetics | 19 |
Antiretroviral Therapy, Highly Active/methods | 12 |
Antiretroviral Therapy, Highly Active/economics | 4 |
Biological Transport, Active/drug effects | 58 |
*Antiretroviral Therapy, Highly Active/methods | 1 |
Active Transport, Cell Nucleus/*physiology | 35 |
Antiretroviral Therapy, Highly Active/*psychology | 6 |
Antiretroviral Therapy, Highly Active/*standards | 1 |
Surface-Active Agents/diagnostic use/pharmacology | 1 |
Antiretroviral Therapy, Highly Active/*trends | 2 |
Antiretroviral Therapy, Highly Active/*methods | 31 |
Active Transport, Cell Nucleus/*genetics | 5 |
Biological Transport, Active/genetics/immunology | 4 |
Active Transport, Cell Nucleus/physiology | 60 |
Antiretroviral Therapy, Highly Active/*utilization | 4 |
*Active Transport, Cell Nucleus/drug effects | 1 |
Antiretroviral Therapy, Highly Active/*adverse effects | 27 |
Antiretroviral Therapy, Highly Active/*methods/utilization | 1 |
Surface-Active Agents/adverse effects/pharmacology | 1 |
Antiretroviral Therapy, Highly Active/*methods/standards | 1 |
Surface-Active Agents/chemical synthesis/pharmacology | 1 |
Antiretroviral Therapy, Highly Active/*economics/*utilization | 1 |
Surface-Active Agents/chemistry/pharmacokinetics/pharmacology | 1 |
Active Transport, Cell Nucleus/genetics/immunology | 1 |
Antiretroviral Therapy, Highly Active/adverse effects | 18 |
*Antiretroviral Therapy, Highly Active/adverse effects | 11 |
Active Transport, Cell Nucleus/drug effects | 36 |
